What are the best alternatives if I cannot get Ozempic, and who prescribes them online?

Short answer: several other GLP‑1 drugs (same class as Ozempic) and other diabetes/weight‑loss medicines can be used instead, and many telehealth companies and online specialty clinics will evaluate you and — where state law and clinical appropriateness allow — prescribe them. Below is a concise list of alternatives and common online prescribers.

Alternatives to Ozempic (by drug/brand and why)

• Semaglutide (other formulations)
  • Wegovy — semaglutide FDA‑approved specifically for chronic weight management (higher dose than Ozempic’s label for diabetes).
  • Rybelsus — oral semaglutide (pill) for type 2 diabetes if you prefer an oral option.
• Tirzepatide
  • Mounjaro (for type 2 diabetes) and Zepbound (approved for weight management) — very effective for glucose lowering and weight loss in recent studies.
• Other GLP‑1 receptor agonists
  • Trulicity (dulaglutide), Victoza (liraglutide), Saxenda (liraglutide for weight-loss), Bydureon/Byetta (exenatide) — weekly or daily injectable options that may be appropriate depending on needs.
• Non‑GLP‑1 glucose‑lowering drugs (often used alone or with GLP‑1s)
  • Metformin — first‑line for type 2 diabetes, inexpensive and widely available.
  • SGLT2 inhibitors (Jardiance/empagliflozin, Farxiga/dapagliflozin, Invokana/canagliflozin) — lower glucose and have heart/kidney benefits for many patients.
  • DPP‑4 inhibitors (Januvia/sitagliptin) — milder glucose lowering, oral.
  • Insulin (basal/bolus) — when GLP‑1s or oral drugs aren’t sufficient.
• Non‑drug options (to consider in parallel)
  • Structured lifestyle/medical weight‑management programs, behavioral counseling, and bariatric surgery (for eligible patients).

Things to know

• Some diabetes brands are approved for diabetes but used off‑label for weight loss (and vice versa). Choice depends on your diagnosis (type 2 diabetes vs. weight management), medical history, and insurance.
• Availability and insurance coverage vary widely; cost can be a limiting factor.
• Safety: all these drugs have contraindications and side effects (e.g., GI effects, pancreatitis risk concerns, thyroid nodule warnings for some). You need a clinician review and periodic monitoring.

Online prescribers / telehealth services that commonly evaluate and prescribe GLP‑1s and other diabetes/weight medications (Availability varies by state; each service requires an online visit and clinical assessment.)

• PlushCare — virtual primary care and chronic‑care visits; commonly prescribes GLP‑1s and diabetes meds where appropriate.
• Ro (Roman) — offers weight‑loss treatment programs and telehealth prescribing of GLP‑1s in many states.
• Hims & Hers — has a telehealth weight‑loss/medical program and may prescribe semaglutide/tirzepatide in select regions.
• GoodRx Care (HeyDoctor) — online visits for chronic conditions; can prescribe diabetes medicines and some weight‑loss drugs depending on the clinician and state rules.
• Lemonaid Health — offers online consults and prescriptions for diabetes and weight‑loss meds in participating states.
• Calibrate — medically supervised weight‑loss program that partners with clinicians to prescribe GLP‑1s and provide coaching.
• Onduo (Verily/Google partner) — diabetes care platform that connects patients with clinicians and may manage prescriptions as part of structured diabetes care.
• Large telehealth platforms / virtual urgent care that can connect you to primary care or specialists: Teladoc, Amwell, One Medical (membership model) — these can often arrange prescriptions or referrals.
• Specialty virtual endocrinology clinics — you can search for tele‑endocrinologists who will evaluate complex cases and prescribe alternatives when indicated.

How to proceed

1. See a clinician (telehealth or your PCP/endocrinologist) to review your medical history, current meds, and goals (diabetes control vs. weight loss).
2. Ask about specific alternatives (e.g., Rybelsus if you prefer oral; Mounjaro/Zepbound or Wegovy for weight loss; or a basal insulin/SGLT2 if GLP‑1s aren’t suitable).
3. Check insurance coverage and prior‑authorization requirements (many GLP‑1s require PA).
4. Avoid sites that sell injectable meds without a proper telehealth visit and prescriptions — safety and legitimacy matter.

If you’d like, tell me:

• whether your primary goal is diabetes control or weight loss,
• your state (so I can mention telehealth services that operate there), and I can suggest the most appropriate alternatives and a few specific telehealth options that are likely to prescribe them in your area.